NCT02557789View on ClinicalTrials.gov

Bioavailability and Pharmacokinetics of Lefamulin When Administered to Fed and Fasted Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

June 30, 2015

Study Completion Date

June 30, 2015

Conditions
Healthy
Interventions
DRUG

Lefamulin

Lefamulin administered iv or orally in the fasted state and orally in the fed state

Trial Locations (1)

NG11 9JS

Quotient Clinical, Nottingham

Sponsors
All Listed Sponsors
lead

Nabriva Therapeutics AG

INDUSTRY

NCT02557789 - Bioavailability and Pharmacokinetics of Lefamulin When Administered to Fed and Fasted Healthy Subjects | Biotech Hunter | Biotech Hunter